Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA GMP Dispute Resolution Guidance Allows 10 Days To Raise Objections

Executive Summary

FDA's dispute resolution draft guidance will allow manufacturers 10 days to challenge FDA inspection findings

You may also be interested in...



GMP Dispute Resolution Pilot To Cover Scientific And Technical Issues Only

An FDA dispute resolution pilot will cover scientific and technical Good Manufacturing Practice issues but not procedural or administrative matters

“Honest And Straightforward” 483 Responses May Avert Warning Letters

CDER is weighing companies' responses to FDA-483 inspection reports in considering whether to issue warning letters, Center for Drug Evaluation & Research Office of Compliance Director David Horowitz said

“Honest And Straightforward” 483 Responses May Avert Warning Letters

CDER is weighing companies' responses to FDA-483 inspection reports in considering whether to issue warning letters, Center for Drug Evaluation & Research Office of Compliance Director David Horowitz said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel